Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference46 articles.
1. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWIG). General Methods. 2022. https://www.iqwig.de/methoden/general-methods_version-6-1.pdf. Accessed 15 Aug 2022.
2. National Institute for Health and Care Excellence (NICE). Single technology appraisal and highly specialised technologies evaluation: User guide for company evidence submission template. 2022. https://www.nice.org.uk/process/pmg24/resources. Accessed 1 Nov 2022.
3. Yu Y, Zhu F, Zhang W, Lu S. Comparison of efficacy and safety of brigatinib in first-line treatments for patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer: a systematic review and indirect treatment comparison. J Clin Med. 2022;11(11):2963.
4. Privitera M, Richy FF, Schabert VF. Indirect treatment comparison of cenobamate to other ASMs for the treatment of uncontrolled focal seizures. Epilepsy Behav. 2022;126: 108429.
5. Menzies-Gow A, Steenkamp J, Singh S, Erhardt W, Rowell J, Rane P, et al. Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparison. J Med Econ. 2022;25(1):679–90.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献